The major clinical indication for antiplatelet therapy has been the prevention of arterial
thrombosis. Arterial thrombi are composed of predominantly platelets formed under conditions of …

… Dual antiplatelet therapy (DAPT) usually refers to the administration of aspirin plus a platelet
… whether the optimal treatment regimen for their patients is mono antiplatelet therapy (MAPT) …

… There was no appreciable evidence that either a higher aspirin dose or any other antiplatelet
regimen was more effective than medium dose aspirin in preventing vascular events. The …

… and compared antiplatelet therapy versus control in high-risk patients (2), antiplatelet therapy
was … algorithms will enhance the safety and efficacy of triple therapy regimens in the future. …

… of antiplatelet therapy versus no antiplatelet therapy, or of one antiplatelet regimen versus …
group differed from that in the other in some aspect other than antiplatelet therapy). Nor were …

… their physicians to know which study regimen they were receiving. This knowledge could
have influenced clinical decisions regarding other medical therapy or procedures. However, no …

… and results of new trials comparing dual antithrombotic regimens, clinicians need to carefully
assess the balance between benefit and harm of antithrombotic therapy in each patient. …

… (TAVI), but the optimal antiplatelet regimen is uncertain and remains to be determined. The
… antiplatelet therapy in patients undergoing TAVI. A strategy using monoantiplatelet therapy (…

… antiplatelet therapy versus control and 4000 such patients were in trials directly comparing
different antiplatelet regimens… ' of all randomised trials of antiplatelet therapy in which vascular …

… antiplatelet therapy with aspirin alone or more commonly with a dual antiplatelet regimen, …
anticoagulation and antiplatelet therapy is a common therapeutic regimen encountered in …